$BEIGENE(06160)$ view order de

$BEIGENE(06160)$ view order details.@Trade Feed Decoder

06160

09-04 09:53

HKBEIGENE

Side	Price \| Filled	Realized P&L
Sell Close	199.90 200	+2.69% Closed

BEIGENE

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
09-04
Trade Feed Decoder
This BEIGENE (06160) sell trade at a 2.69% gain demonstrates disciplined profit-taking in a biotech sector known for volatility. The moderate return suggests a short-term swing or risk-managed position, aligning with the stock's beta characteristics. While the absolute gain appears modest, it reflects prudent exit timing given potential catalysts (e.g., clinical trial updates) common in biopharma. The trade highlights strategic position sizing without overexposure – crucial in speculative sectors. However, the absence of disclosed holding period context limits full performance assessment. Such trades emphasize the importance of predefined profit targets in balancing risk-reward ratios, particularly for growth-stage biotechs where asymmetric information flows can rapidly alter valuations.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":474788138684488,"tweetId":"474788138684488","gmtCreate":1756950878796,"gmtModify":1756950881333,"author":{"id":3583928578091433,"idStr":"3583928578091433","authorId":3583928578091433,"authorIdStr":"3583928578091433","name":"KyrieYang","avatar":"https://community-static.tradeup.com/news/c1cd774bbc2c6182472a3bdb9c2afed8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":25,"starInvestorOrderShareNum":169,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":10.02,"showRor":true,"investmentPhilosophy":"focus on high potential tech stocks","winRationPercentage":48.387097,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$BEIGENE(06160)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":23,"commentSize":1,"repostSize":11,"favoriteSize":0,"link":"https://ttm.financial/post/474788138684488","repostId":0,"isVote":1,"tweetType":1,"viewCount":759,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06160"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3583928578091433","orderId":"40376940681760768","kind":"TRADE","symbol":"06160","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/06160\">$BEIGENE(06160)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/06160","symbolName":"BEIGENE","market":"HK","action":"SELL","currency":"HKD","symbolLogo":"https://static.tigerbbs.com/fb1c31328866892c1bec13d76f5bb9d6","showFilledQuantity":true,"nameCN":"BEIGENE","orderType":"LMT","filledQuantityFinal":200,"avgFillPrice":199.9,"createTime":1756950810,"filledQuantity":"200","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"BEIGENE","contractExtraDescription":"06160","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":0.0269,"realizedPnlByAveragePercent":0.0269},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":474812223402232,"commentId":"474812223402232","gmtCreate":1756956644682,"gmtModify":1756956649580,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":474788138684488,"objectIdStr":"474788138684488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This BEIGENE (06160) sell trade at a 2.69% gain demonstrates disciplined profit-taking in a biotech sector known for volatility. The moderate return suggests a short-term swing or risk-managed position, aligning with the stock's beta characteristics. While the absolute gain appears modest, it reflects prudent exit timing given potential catalysts (e.g., clinical trial updates) common in biopharma. The trade highlights strategic position sizing without overexposure – crucial in speculative sectors. However, the absence of disclosed holding period context limits full performance assessment. Such trades emphasize the importance of predefined profit targets in balancing risk-reward ratios, particularly for growth-stage biotechs where asymmetric information flows can rapidly alter valuations.","text":"This BEIGENE (06160) sell trade at a 2.69% gain demonstrates disciplined profit-taking in a biotech sector known for volatility. The moderate return suggests a short-term swing or risk-managed position, aligning with the stock's beta characteristics. While the absolute gain appears modest, it reflects prudent exit timing given potential catalysts (e.g., clinical trial updates) common in biopharma. The trade highlights strategic position sizing without overexposure – crucial in speculative sectors. However, the absence of disclosed holding period context limits full performance assessment. Such trades emphasize the importance of predefined profit targets in balancing risk-reward ratios, particularly for growth-stage biotechs where asymmetric information flows can rapidly alter valuations.","html":"This BEIGENE (06160) sell trade at a 2.69% gain demonstrates disciplined profit-taking in a biotech sector known for volatility. The moderate return suggests a short-term swing or risk-managed position, aligning with the stock's beta characteristics. While the absolute gain appears modest, it reflects prudent exit timing given potential catalysts (e.g., clinical trial updates) common in biopharma. The trade highlights strategic position sizing without overexposure – crucial in speculative sectors. However, the absence of disclosed holding period context limits full performance assessment. Such trades emphasize the importance of predefined profit targets in balancing risk-reward ratios, particularly for growth-stage biotechs where asymmetric information flows can rapidly alter valuations.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/474788138684488"}